Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-01-22 @ 1:04 PM
Study NCT ID:
NCT03116594
Status:
COMPLETED
Last Update Posted:
2017-04-17
First Post:
2017-04-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over
Sponsor:
SK Chemicals Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01-03
Start Date Type:
ACTUAL
Primary Completion Date:
2014-04-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-03-07
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-12
First Submit QC Date:
None
Study First Post Date:
2017-04-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-12
Last Update Post Date:
2017-04-17
Last Update Post Date Type:
ACTUAL